PE Fund Floats Sorrento An Offer At Roughly $1B Valuation
Sorrento Therapeutics said Friday it received an acquisition offer from an unnamed private equity fund to take on the majority or all of the biopharmaceutical company's outstanding shares for $7 apiece....To view the full article, register now.
Already a subscriber? Click here to view full article